MSTN and chronic kidney disease: Sub-cutaneous injections of an anti-MSTN peptibody into mice with CKD suppressed circulating inflammatory cytokines and reversed the loss of body weight and muscle mass, suggesting that MSTN inhibition/antagonism is a new therapeutic opportunity [17,60].